MIIST Therapeutics is a pulmonary drug delivery system and digital platform that enhances the science of inhaled drugs.
MIIST Therapeutics has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
MIIST Therapeutics's investors include Entrepreneurs First, 1517 Fund, Refactor, Freeflow Ventures, StartUp Health.
MIIST Therapeutics is headquartered in Alameda, United States.
MIIST Therapeutics is a pulmonary drug delivery system and digital platform that enhances the science of inhaled drugs.
MIIST Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MIIST Therapeutics — Funding & Investors." VCBacked, February 5, 2025, https://www.vcbacked.co/company/miist-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). MIIST Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/miist-therapeutics
{{cite web |title=MIIST Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/miist-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated